Rose Research Center, LLC
17
1
1
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
11.8%
2 terminated/withdrawn out of 17 trials
85.7%
-0.8% vs industry average
29%
5 trials in Phase 3/4
33%
4 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette
Role: lead
Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders
Role: lead
Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine
Role: lead
Assisting Smokers to Switch to a JUUL E-Cigarette by Devaluing Combustible Cigarettes
Role: lead
Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT
Role: lead
Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study
Role: collaborator
Exploratory Study of Switching From Combustible Cigarettes to the BIDI E-cigarette
Role: lead
Study of EMB-001 as a Potential Smoking Cessation Treatment
Role: collaborator
Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment
Role: lead
Zonisamide/Bupropion Effects on Switching to Electronic Cigarettes
Role: lead
Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction
Role: lead
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
Role: lead
A Comparison of Exhaled Carbon Monoxide Measurements Using the iCOquit Smokerlyzer and Vitalograph Breath CO Monitor vs Carboxyhemoglobin From Venous Samples While Validating a Mobile Research Application
Role: lead
Comparative Tobacco Interventions for Individuals With Severe and Persisting Behavioral Health Disorders
Role: lead
A Study to Characterize Puff Topography With Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers
Role: collaborator
Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
Role: lead
Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers
Role: collaborator
All 17 trials loaded